News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Pierre Blanchard Highlights SBRT as New Option for Small Oral Cavity Cancers
Pierre Blanchard/X
May 4, 2025, 12:45

Pierre Blanchard Highlights SBRT as New Option for Small Oral Cavity Cancers

Pierre Blanchard, Radiation Oncology Clinical Section Chief at Gustave Roussy Cancer Institute, shared a post on X:

“SBRT (6*6Gy) is a new treatment option for small oral cavity cancers (T1-2) at risk of local recurrence after resection (R1, PNI..): Julian Biau reports the STEREOPOSTOP GORTEC 2017-03.

  • Convenient.
  • Fast.
  • Similar outcomes than post op brachy.

Mostly VMAT homogeneous plans.”

Pierre Blanchard highlighted findings from the STEREOPOSTOP GORTEC 2017-03 study, reporting SBRT as a viable post-resection treatment for small oral cavity cancers.

The approach offers convenience, speed, and comparable outcomes to postoperative brachytherapy, with predominantly homogeneous VMAT plans.

Pierre Blanchard Highlights SBRT as New Option for Small Oral Cavity Cancers

More posts featuring Pierre Blanchard.

cancer fight against cancer Global fight against cancer Gustave Roussy Cancer Institute Julian Biau OncoDaily Oncology oral cavity cancers Pierre Blanchard radiation oncology SBRT STEREOPOSTOP GORTEC VMAT homogeneous plans
Special Coverage
Blog
Jul 28, 2025, 10:53
Jeff White: Newly Diagnosed People Should Know There Are Treatment Options
Blog
Jul 28, 2025, 10:43
Al-Ola A Abdallah: Help Choose the Destination for the First International ICE_T Conference 2027!
Insight
Jul 28, 2025, 10:34
Crispin Hiley: No Role for Mediastinal LN Dissection in GGO-Dominant Invasive Lung Adenocarcinoma
Insight
Jul 28, 2025, 10:17
Real-World Insights Into Pulmonary Sarcomatoid Carcinoma, Shared by Laura Alder and Tejas Patil
Blog
Jul 28, 2025, 10:00
Miriam Mutebi: What Does AI Have to Do with African Women Facing Breast Cancer?
Insight
Jul 28, 2025, 09:59
Dr. Daniel Heng – Breakthrough Research Award: Yvonne Awards 2025
Blog
Jul 28, 2025, 09:54
Scientific Progress Drives Development of Therapies Targeting Disease at the Cellular Source - Servier
Blog
Jul 28, 2025, 09:52
Thor Halfdanarson: Bassam Sonbol on Emerging Targets in Gastroesophageal Cancers at MD Education Meeting
Dialogues
Jul 28, 2025, 09:49
Empowering Oncologists: Evolving role of AI in Oncology
Dialogues
Jul 28, 2025, 09:47
How Can We Better Support Cancer Patients? Lidia Schapira Shares Insights | MASCC 2025
Science
Jul 28, 2025, 09:45
Yan Leyfman: When is Risk-Reducing Mastectomy (RRM) Cost-Effective?
Blog
Jul 28, 2025, 09:36
How Reirradiation is Becoming a Key Strategy in Recurrent Glioma Care - ESTRO